Pablo Corral/LinkedIn
Sep 19, 2026, 09:45
Pablo Corral: Is the Classic Model of Hepatic Cholesterol Homeostasis Incomplete?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Justine Cole et al., published in Journal of Clinical Lipidology, adding:
“Cholesterol Homeostasis in the Hepatocyte
An extraordinary and truly challenging paper on cholesterol homeostasis
- The hepatocyte is not a fibroblast. The classic SREBP2–LDLR model may not adequately explain hepatic cholesterol homeostasis.
- Not all cholesterol entering the hepatocyte behaves the same. Its intracellular fate may depend on whether it arrives through LDL, chylomicron remnants, or HDL.
- The apoB100 pathway may function largely as a closed cholesterol loop: liver – VLDL – IDL – LDL – liver.
- Provocative concept: LDL may have no significant physiological role in net cholesterol delivery to peripheral tissues—challenging the traditional ‘LDL delivers cholesterol to cells’ paradigm.
- The proposed ‘channel model’ is not yet proven, but it raises a fundamental question: could LDL be better understood as a metabolic end-product of VLDL metabolism rather than a physiologically required cholesterol-delivery system?
A thought-provoking paper that forces us to reconsider some of the most deeply rooted concepts in lipoprotein physiology.
Congrats Rafael Zubiran and co-authors.”
Title: Cholesterol Homeostasis in the Hepatocyte
Authors: Justine Cole, Iana Pencinaa, Robert Kiss, Rafael Zubiranb, Allan D. Sniderman
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH
-
Nov 12, 2026, 13:00Abdul Mannan: Factor IX Prophylaxis – Can Breakthrough Bleeding Still Occur?
-
Nov 12, 2026, 12:55Clara N.: A United Effort to Reduce the Burden of SCD in Uganda
-
Nov 12, 2026, 12:38Sophia Delicou: Greece and Cyprus Unite to Advance Thalassaemia and Sickle Cell Care
-
Nov 12, 2026, 12:36Wolfgang Miesbach: Three Cleavages, One Key to Factor VIII Activation
-
Nov 12, 2026, 12:04Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?